LOXL2 and cancer: By analyzing the Cancer Cell Line Encyclopedia (CCLE)‐associated chemotherapeutics sensitivity (Corsello et al, 2020), we observed that high levels of LOXL2 expression make cells significantly more sensitive to Vinca alkaloid compounds.